Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

11/12/24 9:50:11 AM ET

Medical/Dental Instruments

Health Care

Get the next $SKIN alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.7 BEAUTY HEALTH CO/THE CLASS A COMMON STOCK Cusip #88331L108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #88331L108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 18,603,037 Item 6: 0 Item 7: 18,603,037 Item 8: 0 Item 9: 18,603,037 Item 11: 14.999% Item 12: HC Cusip #88331L108 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 18,603,037 Item 8: 0 Item 9: 18,603,037 Item 11: 14.999% Item 12: IN Item 1(a). Name of Issuer: BEAUTY HEALTH CO/THE Item 1(b). Address of Issuer's Principal Executive Offices: 2165 SPRING STREET LONG BEACH, CA 90806 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 88331L108 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 18,603,037 (b) Percent of Class: 14.999% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 18,603,037 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE. The interest of Fidelity Growth Company Fund, in the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE, amounted to 6,733,641 shares or 5.429% of the total outstanding CLASS A COMMON STOCK at September 30, 2024. The interest of Fidelity Growth Company Commingled Pool, in the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE, amounted to 8,312,870 shares or 6.702% of the total outstanding CLASS A COMMON STOCK at September 30, 2024. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company * BK * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on November 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE at September 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $SKIN alert in real time by email

Recent Analyst Ratings for

$SKIN

Date	Price Target	Rating	Analyst
11/15/2023	$11.00 → $1.50	Buy → Hold	Jefferies
11/14/2023	$10.00 → $2.50	Buy → Hold	Canaccord Genuity
11/14/2023		Neutral → Underweight	JP Morgan
11/14/2023	$12.00 → $2.00	Overweight → Underweight	Piper Sandler
11/14/2023	$9.00 → $2.50	Outperform → Market Perform	TD Cowen
11/14/2023		Buy → Hold	The Benchmark Company
11/14/2023		Mkt Perform → Underperform	Raymond James
11/14/2023		Outperform → Mkt Perform	William Blair

More analyst ratings

Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

11/12/24 9:50:11 AM ET

$SKIN

Medical/Dental Instruments

Health Care

Get the next $SKIN alert in real time by email

Recent Analyst Ratings for

$SKIN

Date	Price Target	Rating	Analyst
11/15/2023	$11.00 → $1.50	Buy → Hold	Jefferies
11/14/2023	$10.00 → $2.50	Buy → Hold	Canaccord Genuity
11/14/2023		Neutral → Underweight	JP Morgan
11/14/2023	$12.00 → $2.00	Overweight → Underweight	Piper Sandler
11/14/2023	$9.00 → $2.50	Outperform → Market Perform	TD Cowen
11/14/2023		Buy → Hold	The Benchmark Company
11/14/2023		Mkt Perform → Underperform	Raymond James
11/14/2023		Outperform → Mkt Perform	William Blair

More analyst ratings

Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$SKIN

Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$SKIN

$SKIN
Insider Trading

Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 32,357 shares, decreasing direct ownership by 2% to 1,326,305 units (SEC Form 4)

Director Gruber Desiree was granted 73,051 shares, increasing direct ownership by 61% to 192,565 units (SEC Form 4)

Chairman Saunders Brent L was granted 73,051 shares, increasing direct ownership by 1% to 5,994,820 units (SEC Form 4)

$SKIN
Analyst Ratings

The Beauty Health Company downgraded by Jefferies with a new price target

The Beauty Health Company downgraded by JP Morgan

The Beauty Health Company downgraded by Canaccord Genuity with a new price target

$SKIN
Insider Purchases

Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

$SKIN
SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

SEC Form 10-Q filed by The Beauty Health Company

The Beauty Health Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$SKIN
Press Releases

BeautyHealth Reports Second Quarter 2025 Financial Results

BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025

Hydrafacial Unveils New HydraFillic with Pep9™ Skin Booster For Fine Line & Wrinkles

$SKIN
Financials

BeautyHealth Reports Second Quarter 2025 Financial Results

BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025

BeautyHealth Reports First Quarter 2025 Financial Results

$SKIN
Leadership Updates

The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

$SKIN
Large Ownership Changes